mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.002 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |